Rebiotix
Kristi Strandberg is a Senior Scientist II specializing in Microbiology at Rebiotix Inc, with extensive experience in product research and development, assay development, and technical support across various organizations. Previous roles include Staff Scientist at Immunochemistry Technologies, Associate Scientist II at Emergent BioSolutions, and Post Doctoral Researcher at The Ohio State University Medical Center. Kristi has a PhD in Microbiology from the University of Minnesota and a BA in Biology from the College of Saint Benedict and Saint Johns University. Key achievements include significant research on Salmonella enterica lipopolysaccharide modifications and the role of staphylococcal superantigens in pulmonary disease, alongside mentoring and authoring numerous technical documents throughout the career.
Rebiotix
Rebiotix Inc, part of the Ferring Pharmaceuticals Group, is a clinical-stage biotechnology company revolutionizing the treatment of challenging gastrointestinal diseases by harnessing the power of the human microbiome.